Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy

Through this study, we aimed to validate several biomarkers that have been known to possibly predict the outcomes of the trastuzumab and paclitaxel (TP). Human epidermal growth factor 2 (HER2) positive metastatic breast cancer (MBC) patients who had been treated with TP in single institute from 2006...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Minkyu, Koo, Ja Seung, Moon, Young Wha, Park, Byeong-Woo, Kim, Seung Il, Park, Seho, Lee, Soo Hyun, Hong, Soojung, Rha, Sun Young, Chung, Hyun Cheol, Kim, Joo Hang, Sohn, Joohyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447874/
https://www.ncbi.nlm.nih.gov/pubmed/23028798
http://dx.doi.org/10.1371/journal.pone.0045127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447874/
https://www.ncbi.nlm.nih.gov/pubmed/23028798
http://dx.doi.org/10.1371/journal.pone.0045127

Ejemplares similares